https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-01-01 / Nat. Med. 2003 Jan;9(1):13-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-01-01 / Nat. Med. 2003 Jan;9(1):13-42003-01-01 00:00:002019-02-15 09:15:22Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-03-01 / J. Virol. 2002 Mar;76(6):3007-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-03-01 / J. Virol. 2002 Mar;76(6):3007-142002-03-01 00:00:002019-02-15 09:15:23Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-11-01 / Int J Hyperthermia 1997 Nov-Dec;13(6):577-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-11-01 / Int J Hyperthermia 1997 Nov-Dec;13(6):577-861997-11-01 00:00:002019-02-15 09:15:24Extracorporeal whole body hyperthermia treatment of HIV patients, a feasibility study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-09-01 / ASAIO J. 1997 Sep-Oct;43(5):M830-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-09-01 / ASAIO J. 1997 Sep-Oct;43(5):M830-81997-09-01 00:00:002019-02-15 09:15:25Extracorporeal whole body hyperthermia treatments for HIV infection and AIDS
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-03-01 / J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Mar;11(3):271-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-03-01 / J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Mar;11(3):271-811996-03-01 00:00:002019-02-15 09:15:26Effect of whole-body hyperthermia on AIDS patients with Kaposi’s sarcoma: a pilot study
